BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10704742)

  • 1. p53-dependent radioresistance in ovarian carcinoma cell lines.
    Concin N; Zeillinger C; Stimpfel M; Schiebel I; Tong D; Wolff U; Reiner A; Leodolter S; Zeillinger R
    Cancer Lett; 2000 Mar; 150(2):191-9. PubMed ID: 10704742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
    Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
    Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the p53 status, BCL-2 expression and radiation and platinum drug sensitivity of a panel of human ovarian cancer cell lines.
    Pestell KE; Medlow CJ; Titley JC; Kelland LR; Walton MI
    Int J Cancer; 1998 Sep; 77(6):913-8. PubMed ID: 9714063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation.
    Fan S; Twu NF; Wang JA; Yuan RQ; Andres J; Goldberg ID; Rosen EM
    Int J Cancer; 1998 Aug; 77(4):600-9. PubMed ID: 9679765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D; Siré EG; De Feudis P; Vikhanskaya F; Valenti M; Russo P; Parodi S; D'Incalci M; Broggini M
    Cancer Res; 1997 Mar; 57(5):870-4. PubMed ID: 9041188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitivity, apoptosis and repair of DNA double-strand breaks in radiation-sensitive Chinese hamster ovary cell mutants treated at different dose rates.
    Hu Q; Hill RP
    Radiat Res; 1996 Dec; 146(6):636-45. PubMed ID: 8955713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity.
    Gallardo D; Drazan KE; McBride WH
    Cancer Res; 1996 Nov; 56(21):4891-3. PubMed ID: 8895740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to p53-mediated growth suppression in human ovarian cancer cells retain endogenous wild-type p53.
    Jin X; Burke W; Rothman K; Lin J
    Anticancer Res; 2002; 22(2A):659-64. PubMed ID: 12014634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status.
    De Feudis P; Debernardis D; Beccaglia P; Valenti M; Graniela Siré E; Arzani D; Stanzione S; Parodi S; D'Incalci M; Russo P; Broggini M
    Br J Cancer; 1997; 76(4):474-9. PubMed ID: 9275024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional restoration of tumor suppressor p53 alters susceptibility of glioblastoma cells to irradiation--analysis using a cell line containing a temperature-sensitive mutant].
    Tsuchiya K
    Hokkaido Igaku Zasshi; 2000 Jul; 75(4):265-74. PubMed ID: 10976406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro.
    Karlan BY; Amin W; Band V; Zurawski VR; Littlefield BA
    Gynecol Oncol; 1988 Sep; 31(1):103-12. PubMed ID: 3410341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.
    Akeshima R; Kigawa J; Takahashi M; Oishi T; Kanamori Y; Itamochi H; Shimada M; Kamazawa S; Sato S; Terakawa N
    Br J Cancer; 2001 Jun; 84(11):1551-5. PubMed ID: 11384107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
    Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
    Aldridge DR; Radford IR
    Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.
    Yaginuma Y; Westphal H
    Cancer Res; 1992 Aug; 52(15):4196-9. PubMed ID: 1638534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.
    Shu HK; Kim MM; Chen P; Furman F; Julin CM; Israel MA
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14453-8. PubMed ID: 9826721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.